Latest filing published 23 Jul 2026 for ALLURION TECHNOLOGIES, INC.. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
RTW Investments, LP has filed trades across 11 companies (mainly through SEC (Form 4)), most often in Renovacor, Inc., Allurion Technologies, Inc. and Orchestra BioMed Holdings, Inc. In total, 38 filings cover trades dated from 26 January 2021 to 21 July 2026.
In open-market terms, that means 16 purchases worth €62.1M on one side and 4 sales worth €35.3M on the other. On balance, insiders were net buyers of €26.8M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 5 share grants. Since January 2026: 1 purchase and 1 sale on the market.
In size, the median ticket on the buying side is €356k. Of 16 purchases, 1 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
The newest entry dates from 23 July 2026: a transaction, in Allurion Technologies, Inc. The last purchase on record was published on 22 April 2026, which is 179 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 38 declarations